Literature DB >> 14662215

Complications associated with global endometrial ablation: the utility of the MAUDE database.

Shawn E Gurtcheff1, Howard T Sharp.   

Abstract

OBJECTIVE: To investigate the number and type of complications associated with global endometrial ablation using public-access governmental databanks.
METHODS: MEDLINE (PubMed) and the US Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE) databases were searched for entries for the four US Food and Drug Administration-approved global endometrial ablation devices.
RESULTS: Traditional MEDLINE and bibliography searches yielded reports of two cases of hemorrhage, one case of pelvic inflammatory disease, 20 cases of endometritis, two cases of first-degree skin burns, nine cases of hematometra, and 16 cases of vaginitis and/or cystitis. A search of the US Food and Drug Administration MAUDE database yielded reports of 85 complications in 62 patients. These included major complications: eight cases of thermal bowel injury, 30 cases of uterine perforation, 12 cases in which emergent laparotomy was required, and three intensive care unit admissions. One patient developed necrotizing fasciitis and eventually underwent vulvectomy, ureterocutaneous ostomy, and bilateral below-the-knee amputations. One of the patients with thermal injury to the bowel died.
CONCLUSION: Use of the US Food and Drug Administration MAUDE database is helpful in identifying serious complications associated with global endometrial ablation not yet reported in the medical literature.

Entities:  

Mesh:

Year:  2003        PMID: 14662215     DOI: 10.1016/j.obstetgynecol.2003.07.007

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  7 in total

Review 1.  The levonorgestrel-releasing intrauterine system in heavy menstrual bleeding: a benefit-risk review.

Authors:  Andrew M Kaunitz; Pirjo Inki
Journal:  Drugs       Date:  2012-01-22       Impact factor: 9.546

2.  Complications associated with transobturator sling procedures.

Authors:  Sarah Hamilton Boyles; Renee Edwards; William Gregory; Amanda Clark
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-03-28

3.  Uterine artery embolisation for acute dysfunctional uterine bleeding with failed medical therapy: a novel approach to management.

Authors:  Chye Lee Kho; Manisha Mathur
Journal:  BMJ Case Rep       Date:  2015-01-16

4.  Prediction of treatment outcomes after global endometrial ablation.

Authors:  Sherif A El-Nashar; Matthew R Hopkins; Douglas J Creedon; Jennifer L St Sauver; Amy L Weaver; Michaela E McGree; William A Cliby; Abimbola O Famuyide
Journal:  Obstet Gynecol       Date:  2009-01       Impact factor: 7.661

5.  Identification and verification of effective components of Huanghuai for dysfunctional uterine bleeding based on network pharmacology and molecular docking.

Authors:  Yun-Xiu Yao; Yu-Ling Xu; Bo-Wen Liu; Hui Yang; Song-Yang Li; Ling-Li Zhazo; Tao Liu
Journal:  Chin Herb Med       Date:  2020-12-25

Review 6.  Ten-year literature review of global endometrial ablation with the NovaSure® device.

Authors:  Richard J Gimpelson
Journal:  Int J Womens Health       Date:  2014-03-11

7.  A Primer to the Structure, Content and Linkage of the FDA's Manufacturer and User Facility Device Experience (MAUDE) Files.

Authors:  Lisa Garnsey Ensign; K Bretonnel Cohen
Journal:  EGEMS (Wash DC)       Date:  2017-06-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.